portion of the uterus influences the electrical properties of the uterus as a whole. Despite sampling benign regions of tissues in a tumorbearing uterus, the overall plots were visually differentiated and classified into one of two discrete groups. These results show promise for use of artificial intelligence in assisting with classifying organs as benign or malignant. Surgical technique differs in removing a tumor-bearing organ versus a non-tumor-bearing organ. Thus, bioimpedance technology may have potential implications in risk assessment of patients and subsequently guide preoperative and intraoperative decision-making.
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OBJECTIVES:
The purpose of this study is to investigate the cost effectiveness and utility of postoperative day #1 routine laboratory hemoglobin and hematocrit tests in patients undergoing pelvic reconstructive surgery. MATERIALS AND METHODS: This is a retrospective chart review of 312 patients who underwent complex pelvic reconstructive surgery including anterior repair, posterior repair, vaginal and abdominal hysterectomy, mid-urethral sling, sacrocolpopexy, and a combination of procedures performed by one surgical practice between 2014 and 2018. Patient demographics, pre-and postoperative hemoglobin and hematocrit levels, estimated blood loss, surgical procedure performed, and transfusions were all recorded. Statistical analysis was performed using parametric T-testing and a P-value of less than 0.05 was considered significant. RESULTS: There were 312 charts available for complete evaluation. The median age of patients was 53.5. Of the charts reviewed, 17 patients did receive a transfusion, 7 patients were transfused intraoperatively, 10 patients were transfused based on clinical symptomatology within the first 24 hours, and 5 patients received a transfusion based on their postoperative day #1 hemoglobin and hematocrit. Patients who did receive a transfusion had a lower preoperative hemoglobin of 11.59 (SD¼3.081) and a preoperative hematocrit of 35.42 (SD¼7.795). There was a statistically significant difference in the preoperative hemoglobin and hematocrit using a Ttest and assuming unequal variance. There was a weak correlation with the procedure performed. Abdominal hysterectomy with enlarged uterus had a higher intraoperative estimated blood loss, lower preoperative hematocrit, and more transfusions. The cost associated with performing these lab tests was approximately $93,000 with a cost estimate of $300 per patient. CONCLUSION: This study suggests that routine postoperative day #1 hemoglobin and hematocrit tests can be safely discontinued and are neither cost effective nor warranted. Laboratory testing based on clinical evaluation and preoperative lab values would be more appropriate.
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